Brief: Aura Biosciences To Present Updated Belzupacap Sarotalocan Data On Multiple Studies
17/06/2022 12:47
June 17 (Reuters) - Aura Biosciences Inc AURA.O :
* AURA BIOSCIENCES TO PRESENT UPDATED BELZUPACAP SAROTALOCAN
(AU-011) DATA ON MULTIPLE STUDIES AT THE INTERNATIONAL SOCIETY
OF OCULAR ONCOLOGY 2022 BI-ANNUAL MEETING
Source text for Eikon: ID:nBw67g8xRa
Further company coverage: AURA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aura Biosciences
See all newsBrief: Aura Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Aura Biosciences - May Offer Securities Up To $500 Million Aggregate
Brief: Aura Biosciences Reports Second Quarter 2026 Financial Results And Recent Business Highlights
U.S. RESEARCH ROUNDUP-Aecom, Humana, Mosaic
Aura Biosciences Q1 net loss widens on higher R&D costs